Arrowhead Pharmaceuticals Inc (ARWR)
followers
·
Follow
1 like
| Sector: | HEALTH CARE |
| Industry: | PHARMACEUTICALS |
| SIC: | PHARMACEUTICAL PREPARATIONS |
| CEO: | Christopher R. Anzalone |
| Employees: | 400 |
| Web site: | arrowheadpharma.com |
|
177 E COLORADO BLVD, SUITE 700, PASADENA, CA, 91105
626-696-4702
| |
-
Formally known as:
- Arrowhead Research Corp
- Arrowhead Research Corp
| Date | Ratio |
|---|---|
| 2004-01-15 | 1:65 |
| 2011-11-17 | 1:10 |
| All 13F Filers | Prior | Change | Hedge Funds 1 | Prior | Change |
|---|
Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company's products in pipeline includes ARO-AAT, a RNA interference (RNAi) therapeutic candidate that is in Phase II clinical trial for the. treatment of liver diseases associated with alpha-1 antitrypsin deficiency. ARO is also involved in the development of JNJ-3989, a subcutaneously administered RNAi therapeutic candidate to treat chronic hepatitis B virus infection; Olpasiran to reduce the production of apolipoprotein A.
Please log in first to see chart